Bradley J Beattie
Overview
Explore the profile of Bradley J Beattie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1014
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Grkovski M, Kohutek Z, Schoder H, Brennan C, Tabar V, Gutin P, et al.
Eur J Nucl Med Mol Imaging
. 2019 Dec;
47(6):1446-1457.
PMID: 31865407
Purpose: Radiographic changes of brain metastases after stereotactic radiosurgery (SRS) can signify tumor recurrence and/or radiation necrosis (RN); however, standard imaging modalities cannot easily distinguish between these two entities. We...
12.
Timmermand O, Elgqvist J, Beattie K, Orbom A, Larsson E, Eriksson S, et al.
Theranostics
. 2019 Jun;
9(8):2129-2142.
PMID: 31149033
Androgen ablating drugs increase life expectancy in men with metastatic prostate cancer, but resistance inevitably develops. In a majority of these recurrent tumors, the androgen axis is reactivated in the...
13.
Beattie B
J Appl Clin Med Phys
. 2019 Jan;
20(2):154-156.
PMID: 30652408
Objectives: The phantom filling procedures currently specified by the American College of Radiology (ACR) for its PET accreditation program unnecessarily limit how tight the tolerances can be made on the...
14.
Krebs S, Pandit-Taskar N, Reidy D, Beattie B, Lyashchenko S, Lewis J, et al.
Eur J Nucl Med Mol Imaging
. 2018 Oct;
46(3):677-685.
PMID: 30374529
Purpose: Somatostatin receptor antagonists have shown promise for imaging neuroendocrine tumors (NETs) in preclinical studies, but clinical data is still very limited. In this study, we assess the feasibility of...
15.
McDevitt M, Thorek D, Hashimoto T, Gondo T, Veach D, Sharma S, et al.
Nat Commun
. 2018 Apr;
9(1):1629.
PMID: 29691406
Human kallikrein peptidase 2 (hK2) is a prostate specific enzyme whose expression is governed by the androgen receptor (AR). AR is the central oncogenic driver of prostate cancer (PCa) and...
16.
Vargas H, Kramer G, Scott A, Weickhardt A, Meier A, Parada N, et al.
J Nucl Med
. 2018 Apr;
59(10):1516-1523.
PMID: 29626121
F-fluorodihydrotestosterone (F-FDHT) is a radiolabeled analog of the androgen receptor's primary ligand that is currently being credentialed as a biomarker for prognosis, response, and pharmacodynamic effects of new therapeutics. As...
17.
Dunphy M, Harding J, Venneti S, Zhang H, Burnazi E, Bromberg J, et al.
Radiology
. 2018 Feb;
287(2):667-675.
PMID: 29388903
Purpose To assess the clinical safety, pharmacokinetics, and tumor imaging characteristics of fluorine 18-(2S,4R)-4-fluoroglutamine (FGln), a glutamine analog radiologic imaging agent. Materials and Methods This study was approved by the...
18.
Alidori S, Thorek D, Beattie B, Ulmert D, Almeida B, Monette S, et al.
PLoS One
. 2017 Aug;
12(8):e0183902.
PMID: 28846728
Nanomedicine rests at the nexus of medicine, bioengineering, and biology with great potential for improving health through innovation and development of new drugs and devices. Carbon nanotubes are an example...
19.
Grkovski M, Lee N, Schoder H, Carlin S, Beattie B, Riaz N, et al.
Eur J Nucl Med Mol Imaging
. 2017 May;
44(10):1682-1691.
PMID: 28540417
Purpose: There is growing recognition that biologic features of the tumor microenvironment affect the response to cancer therapies and the outcome of cancer patients. In head and neck cancer (HNC)...
20.
Schmidtlein C, Lin Y, Li S, Krol A, Beattie B, Humm J, et al.
Med Phys
. 2017 Apr;
44(8):4083-4097.
PMID: 28437565
Purpose: Performance of the preconditioned alternating projection algorithm (PAPA) using relaxed ordered subsets (ROS) with a non-smooth penalty function was investigated in positron emission tomography (PET). A higher order total...